Clinical trials
Observational Bacterial Infections trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 2 |
| 2012 | 3 |
| 2016 | 4 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Recruiting | 3 |
| Unknown status | 3 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 5 |
| Centre Hospitalier Universitaire, Amiens | 2 |
| University Hospital, Strasbourg, France | 2 |
| Central Hospital, Nancy, France | 1 |
| Centre Hospitalier de Saint-Denis | 1 |
| Centre d'Investigation Clinique et Technologique 805 | 1 |
| Correvio International Sarl | 1 |
| Fondation Hôpital Saint-Joseph | 1 |
| Gérond'if | 1 |
| Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bacterial Infections | 24 |
| Fever | 5 |
| Bacteremia | 2 |
| Staphylococcal Infections | 2 |
| Death | 1 |
| Disease | 1 |
| Gram-Positive Bacterial Infections | 1 |
| HIV Infections | 1 |
| Hyperthermia | 1 |
| Infections | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.